Drug interactions are actually the greatest impediment in managing HIV/HCV co-infected clients. With regard to safety results, tenofovir DF employed with ledipasvir or velpatasvir can lead to an increase in serum creatinine, especially when coupled with a pharmacokinetic booster. [139] Using tenofovir DF must be avoided in these scenarios in the ev